Microtubule-dependent redistribution of the type-1 inositol 1,4,5-trisphosphate receptor in A7r5 smooth muscle cells
- 1 April 2003
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 116 (7) , 1269-1277
- https://doi.org/10.1242/jcs.00354
Abstract
In A7r5 vascular smooth muscle cells, the two expressed inositol 1,4,5-trisphosphate receptor (IP3R) isoforms were differentially localized. IP3R1 was predominantly localized in the perinuclear region, whereas IP3R3 was homogeneously distributed over the cytoplasm. Prolonged stimulation (1-5 hours) of cells with 3 μM argininevasopressin induced a redistribution of IP3R1 from the perinuclear region to the entire cytoplasm, whereas the localization of IP3R3 appeared to be unaffected. The redistribution process occurred independently of IP3R downregulation. No structural changes of the endoplasmic reticulum were observed, but SERCA-type Ca2+ pumps redistributed similarly to IP3R1. The change in IP3R1 localization induced by arginine-vasopressin could be blocked by the simultaneous addition of nocodazole or taxol and depended on Ca2+ release from intracellular stores since Ca2+-mobilizing agents such as thapsigargin and cyclopiazonic acid could induce the redistribution. Furthermore, various protein kinase C inhibitors could inhibit the redistribution of IP3R1, whereas the protein kinase C activator 1-oleoyl-2-acetyl-sn-glycerol induced the redistribution. Activation of protein kinase C also induced an outgrowth of the microtubules from the perinuclear region into the cytoplasm, similar to what was seen for the redistribution of IP3R1. Finally, blocking vesicular transport at the level of the intermediate compartment inhibited the redistribution. Taken together, these findings suggest a role for protein kinase C and microtubuli in the redistribution of IP3R1, which probably occurs via a mechanism of vesicular trafficking.Keywords
This publication has 41 references indexed in Scilit:
- The Ankyrin-B C-terminal Domain Determines Activity of Ankyrin-B/G Chimeras in Rescue of Abnormal Inositol 1,4,5-Trisphosphate and Ryanodine Receptor Distribution in Ankyrin-B (−/−) Neonatal CardiomyocytesJournal of Biological Chemistry, 2002
- Mapping of the ATP-binding Sites on Inositol 1,4,5-Trisphosphate Receptor Type 1 and Type 3 Homotetramers by Controlled Proteolysis and Photoaffinity LabelingPublished by Elsevier ,2001
- Microtubules Regulate Local Ca2+ Spiking in Secretory Epithelial CellsJournal of Biological Chemistry, 2000
- Molecular properties of inositol 1,4,5-trisphosphate receptorsCell Calcium, 1999
- Agonist-induced down-regulation of type 1 and type 3 inositol 1,4,5-tris-phosphate receptors in A7r5 and DDT1 MF-2 smooth muscle cellsCell Calcium, 1998
- Probing of the Membrane Topology of Sarcoplasmic Reticulum Ca2+-ATPase with Sequence-specific AntibodiesJournal of Biological Chemistry, 1997
- Threshold for Inositol 1,4,5-Trisphosphate ActionPublished by Elsevier ,1996
- Type I, II, and III Inositol 1,4,5-Trisphosphate Receptors Are Unequally Susceptible to Down-regulation and Are Expressed in Markedly Different Proportions in Different Cell TypesJournal of Biological Chemistry, 1995
- Rat basophiliv leukemia cells as model system for inositol 1,4,5-trisphosphate receptor IV, a receptor of the type II family: functional comparison and immunological detectionCell Calcium, 1995
- Imipramine stimulates phospholipase C activity in rat brainNeurochemistry International, 1994